tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Nuvalent initiated with an Outperform at Raymond James
PremiumThe FlyNuvalent initiated with an Outperform at Raymond James
1M ago
Nuvalent initiated with an Overweight at Piper Sandler
Premium
The Fly
Nuvalent initiated with an Overweight at Piper Sandler
2M ago
Nuvalent Reports Q2 2025 Financials and Pipeline Progress
Premium
Company Announcements
Nuvalent Reports Q2 2025 Financials and Pipeline Progress
2M ago
Nuvalent Initiates Phase 3 ALKAZAR Clinical Trial
PremiumCompany AnnouncementsNuvalent Initiates Phase 3 ALKAZAR Clinical Trial
3M ago
Nuvalent doses first patient in Alkazar trial
Premium
The Fly
Nuvalent doses first patient in Alkazar trial
3M ago
Nuvalent’s Promising Biotech Advancements: Buy Rating Backed by Strong Clinical Results
Premium
Ratings
Nuvalent’s Promising Biotech Advancements: Buy Rating Backed by Strong Clinical Results
3M ago
Nuvalent price target raised to $130 from $110 at H.C. Wainwright
PremiumThe FlyNuvalent price target raised to $130 from $110 at H.C. Wainwright
3M ago
Nuvalent’s Zidesamib: Promising Best-in-Class ROS1 TKI with Strong Efficacy and Safety Profile
Premium
Ratings
Nuvalent’s Zidesamib: Promising Best-in-Class ROS1 TKI with Strong Efficacy and Safety Profile
3M ago
Nuvalent Announces Positive Data for Zidesamtinib Trial
Premium
Company Announcements
Nuvalent Announces Positive Data for Zidesamtinib Trial
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100